NACE-ABC Regional Programs: Emerging Challenges in Primary Care 2019 – Houston, TX
Houston Marriott West Loop Hotel by the Galleria
1750 West Loop South
Houston, TX 77027
Registration Fee
There is no registration fee for this activity.
Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.
Event Parking
A discounted self parking rate of $5.00 is available at the hotel. Valet parking is also available at the hotel for $20.00 per day.
Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.
We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.
Please join us and become an active participant in this one-day learning community of your peers.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Learn when clinical symptoms are indicative of functional disorders rather than disease; Become familiar with ongoing endocrine disorders in primary care patients; Understand pituitary function in health and disease; Differentiate among adrenal disorders of hypo and hyperfunction; Successfully treat “symptomatic” thyroid patients.
- Evaluate the physiological role of GLP-1 and associated implications for the treatment of patients with Diabetes; Review recommendations from current diabetes guidelines regarding the use of GLP-1 receptor agonists; Determine the advantages and disadvantages of individual GLP-1 receptor agonists in terms of efficacy, tolerability, dosing, frequency, and administration requirements; Assess the effect of GLP-1 receptor agonists on glycemic and extra-glycemic outcomes; Discuss strategies for reducing adverse effects in patients receiving GLP-1 receptor agonists.
- Discuss the latest 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol to reduce the risk of cardiovascular disease; Incorporate current data surrounding non-statin therapy into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Overcome barriers to access for PCSK9 monoclonal antibody therapy.
- Recognize the association between hypertriglyceridemia and atherosclerotic cardiovascular disease (ASCVD); Discuss the different biologic properties of omega-3 fatty acids and their impact on lipid levels; Identify patients who might benefit from triglyceride lowering; Utilize evidence-based approaches to manage patients with hypertriglyceridemia.
- Describe the pathogenesis of atopic dermatitis (AD), particularly the role of the Th2 pathway; Demonstrate increased ability to recognize the clinical presentations and differential diagnosis of AD; Discuss the current research and trial data supporting treatment options for AD; Individualize AD treatment with consideration to the full spectrum of treatment options and disease severity; Recognize the risks and safety profiles of current treatments for effective AD management; Integrate the recognition of comorbidities into the management AD.
Agenda*
7:30 – 8:00 am
Continental Breakfast and Registration
8:00 – 8:10
Welcome Remarks – Marlene Wolf, MD
8:10 – 9:20
Primary Care Endocrinology: The Common and Not So Common
Mark Stolar, MD
9:20 – 10:30
A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How
Mark Stolar, MD
10:30 – 10:50
Break
10:50 – 12:00 pm
Pushing the Threshold of Lipid Lowering: Incorporating the Evolving Database into Practice
David N. Smith, MD
12:00 – 1:10
Lunch
1:10 – 2:20
Cardiovascular Disease and Hypertriglyceridemia: The Evolving Link
David N. Smith, MD
2:20 – 3:30
Addressing Type 2 Inflammation in Atopic Dermatitis: Individualizing Care Across Populations
Khanh “Connie” Nguyen, MD
3:30 – 3:45
Summary of Key Points and Closing Remarks
*Agenda subject to change
Faculty
Khanh “Connie” Nguyen, MD
Director of Premier Derm Center
Houston, TX
Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL
David N. Smith, MD
Clinical Assistant Professor of Medicine, Yale University
Associate Professor of Medicine
Wingate University Physician Assistant Program
Charlotte, NC
Moderator
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
Planning Committee
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL
Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education
Plantation, FL
Michelle Frisch, MPH, CHCP
Vice President of Operations
National Association for Continuing Education
Plantation, FL
Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA
Cedric Nazareth, MBBS
Medical Writer
Cedric Nazareth Medical Writing
Mississauga, ON
Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA
Cassandra A. McCullough, MBA
Chief Executive Officer
Association of Black Cardiologists
New York, NY
John Guerriero, MBA
Director of Learning and Development
Med Learning Group
New York, NY
Ana Maria Albino
Program Manager
Med Learning Group
New York, NY
Lauren Welch, MA
Vice President, Outcomes and Accreditation
Med Learning Group
New York, NY
Sponsored and Certified By
National Association for Continuing Education
Accreditation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The National Association for Continuing Education designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NACE AANP Approval
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 5.0 Contact hour(s) of continuing education including 2.5 pharmacology hours.
Sponsored and Certified By
The Association of Black Cardiologists, Inc.
Accreditation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsored and Certified By
Med Learning Group and co-provided by Ultimate Medical Academy/CCM
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity was planned and produced in accordance with the ACCME Essentials.
Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in treating and managing patients with diabetes. CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
Faculty Disclosure Statement
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. All planners are also required to disclose all relevant financial relationships. Disclosure information will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Novo Nordisk; and by an educational grant from Sanofi US and Regeneron Pharmaceuticals.